MeiraGTx Holdings Plc (MGTX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about MeiraGTx Holdings Plc (MGTX)
Company Performance

Current Price

as of Oct 16, 2024

$5.92

P/E Ratio

N/A

Market Cap

$458.2M

Description

MeiraGTx Holdings Plc engages in the development of novel gene therapy treatments. The company was founded on March 20, 2015 and is headquartered in New York, NY.

Metrics

Overview

  • HQNew York, NY
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerMGTX
  • Price$5.92+11.07%

Trading Information

  • Market Cap$458.20M
  • Float67.23%
  • Average Daily Volume (1m)317,218
  • Average Daily Volume (3m)231,250
  • EPS-$1.50

Company

  • Revenue$8.12M
  • Rev Growth (1yr)-92.03%
  • Net Income-$48.62M
  • Gross Margin-1,042.55%
  • EBITDA Margin-15,137.23%
  • EBITDA-$42.69M
  • EV$258.62M
  • EV/Revenue31.84
  • P/EN/A
  • P/S46.92
  • P/B4.78
Documents